Bibliographic Details
| Title: |
Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose. |
| Authors: |
Gallagher, Megan C., Haessler, Sarah, Pecoy-Whitcomb, Elizabeth, Bayuk, Jonathan |
| Source: |
Allergy & Asthma Proceedings; Jan2022, Vol. 43 Issue 1, p37-39, 3p |
| Subject Terms: |
COVID-19 vaccines, COVID-19, MESSENGER RNA, ALLERGIES, IMMUNOLOGISTS |
| Company/Entity: |
CENTERS for Disease Control & Prevention (U.S.) |
| Abstract: |
Background: After Emergency Use Authorization of the coronavirus disease 2019 (COVID-19) vaccines, guidance was provided by the Centers for Disease Control and Prevention that persons with an immediate allergic reaction to a messenger RNA (mRNA) COVID-19 vaccine should be evaluated by an allergist/immunologist before receipt of the second dose. Methods: In vaccinating health-care personnel, we referred those with significant reactions to allergy/immunology specialists so that they could safely receive the second dose. Results: We found that many reactions after the first dose were nonallergic but could be debilitating and a barrier to the second dose. We created a protocol of premedications to allow health-care personnel to safely receive their second mRNA COVID-19 vaccine dose. Conclusion: This protocol is adaptable and can be used in settings where allergy/immunology referral is not immediately available. [ABSTRACT FROM AUTHOR] |
|
Copyright of Allergy & Asthma Proceedings is the property of OceanSide Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Supplemental Index |
